JHIU
GEVA

Janus Henderson Investors US’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Janus Henderson Investors US’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-572,037
Closed -$55.8M – 1170
2015
Q1 		$55.8M Sell
572,037
-280,815
-33% -$29.7M 0.05% 429
2014
Q4 		$79.1M Buy
852,852
+29,364
+4% +$2.32M 0.07% 352
2014
Q3 		$56.6M Buy
823,488
+45,382
+6% +$3.25M 0.05% 390
2014
Q2 		$81.5M Sell
778,106
-52,474
-6% -$4.46M 0.07% 318
2014
Q1 		$68.9M Sell
830,580
-220,147
-21% -$20.4M 0.06% 349
2013
Q4 		$68M Sell
1,050,727
-195,663
-16% -$11.6M 0.06% 336
2013
Q3 		$78.9M Buy
1,246,390
+29,468
+2% +$1.45M 0.08% 285
2013
Q2 		$51.1M Buy
+1,216,922
New +$55.5M 0.05% 358

Janus Henderson Investors US's GEVA Position: Q2 2015 in Review

Janus Henderson Investors US sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 572,037 shares — an estimated $55.8M sold.

Janus Henderson Investors US first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $81.5M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Janus Henderson Investors US reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Janus Henderson Investors US sold 572,037 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $55.8M.
  • Janus Henderson Investors US first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Janus Henderson Investors US's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $81.5M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Janus Henderson Investors US's 13F filing for Q2 2015, filed 17 Aug 2015.